Search

Your search keyword '"Barranco E"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Barranco E" Remove constraint Author: "Barranco E"
118 results on '"Barranco E"'

Search Results

2. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

6. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

7. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

13. The Gulf of Cadiz: an unstable giant contouritic levee

14. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

19. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

20. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

22. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

23. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3

24. The 'Shackleton Site' (IODP Site U1385) on the Iberian Margin

25. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

26. 211 SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY: THE LARGEST RETROSPECTIVE STUDY OF ESAS FOR THE TREATMENT OF ANEMIA IN LOWER RISK MDS PATIENTS

27. The 'Shackleton Site' (IODP Site U1385) on the Iberian Margin

31. 1530 – Suicide, religion and holy week

34. Past deep-ocean circulation and the paleoclimate record-Gulf of Cadiz

38. Environmental significance of the Mediterranean Outflow Water and its global implications

39. SPRESAS (SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY) SUBANALYSIS: IMPACT OF COMORBIDITIES AND CENTER LEVEL ON RESPONSE TO ESAS IN LOWER RISK MDS

40. Reclassification after delivery of diabetes in pregnancy

41. SPRESAS (SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY): THE LARGEST RETROSPECTIVE STUDY OF TREATMENT WITH ESAS IN LOWER RISK MDS

42. Formación sobre el burnout realizada desde el trabajo social con profesionales de los servicios de salud: enfoques integrados y estrategias participativas

43. La intervención en trabajo social desde la calidad integrada

47. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

48. Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021

49. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials.

50. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection.

Catalog

Books, media, physical & digital resources